Tanzania Pilot ACT Subsidy

Region: Africa
Country: Tanzania
Client: Clinton Foundation
Date: 2007-2008

The Clinton Foundation conducted a pilot in three districts in Tanzania to test whether a global subsidy for the new artemisinin-based combination therapies (ACTs) for malaria would reach ordinary people. HLSP provided the data collection component and analysis of exit interviews, 'mystery shoppers', retail audits, and public/NGO facility audits. The study showed that uptake of subsidized ACTs was rapid, and that the price in shops was equal to or less than common alternatives. It also showed that there was almost no leakage of subsidised ACT to the control district. Penetration of ACTs into shops in remote areas was slower suggesting that businesses distributing drugs there would need more incentives than were tested in this pilot.

Read the Report on Findings (April 2008) on the Clinton Foundation website.

Technical area:

• Access to medicines
• TB, malaria and other communicable diseases
• Monitoring & evaluation